$MNOV
MEDICINOVA INC

2015 Q1 Form 10-K Financial Statement

#000119312515089483 Filed on March 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $0.00 $0.00 $6.000M
YoY Change -100.0% 17547.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.500M $5.960M $1.630M
YoY Change -7.41% -10.51% -2.98%
% of Gross Profit
Research & Development $600.0K $2.900M $940.0K
YoY Change 0.0% 7.41% 20.51%
% of Gross Profit
Depreciation & Amortization $9.180K $40.19K $10.00K
YoY Change -10.68% -60.01% -66.67%
% of Gross Profit
Operating Expenses $2.215K $9.223M $2.573M
YoY Change -6.3% -7.99% 4.81%
Operating Profit -$2.215M -$9.223M
YoY Change -6.29% 129.4%
Interest Expense $140.00 $628.00 -$10.00K
YoY Change 13.82%
% of Operating Profit
Other Income/Expense, Net $0.00 -$10.00K $0.00
YoY Change -100.0%
Pretax Income -$2.212M -$9.199M $3.410M
YoY Change -5.9% 128.58% -240.33%
Income Tax $2.946K -$3.972K $0.00
% Of Pretax Income 0.0%
Net Earnings -$2.215K -$9.195M $3.413M
YoY Change -5.82% 128.25% -240.22%
Net Earnings / Revenue 56.88%
Basic Earnings Per Share $0.15
Diluted Earnings Per Share -$90.46K -$382.2K $0.14
COMMON SHARES
Basic Shares Outstanding 24.62M shares 22.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.100M $11.70M $6.700M
YoY Change -38.51% 74.63% 67.5%
Cash & Equivalents $9.073M $11.70M $6.700M
Short-Term Investments
Other Short-Term Assets $1.300M $500.0K $1.700M
YoY Change 0.0% -70.59% 325.0%
Inventory
Prepaid Expenses
Receivables $0.00 $6.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.34M $12.10M $14.38M
YoY Change -35.64% -15.97% 225.24%
LONG-TERM ASSETS
Property, Plant & Equipment $35.68K $0.00 $82.41K
YoY Change -52.92% -100.0% 5.02%
Goodwill $9.600M $9.600M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $700.0K $700.0K $700.0K
YoY Change 0.0% 0.0% 0.0%
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $15.13M $15.20M $15.16M
YoY Change -0.16% 0.66% 0.12%
TOTAL ASSETS
Total Short-Term Assets $10.34M $12.10M $14.38M
Total Long-Term Assets $15.13M $15.20M $15.16M
Total Assets $25.47M $27.30M $29.55M
YoY Change -18.42% -7.46% 50.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $110.4K $500.0K $33.89K
YoY Change -28.26% -93.11%
Accrued Expenses $396.6K $1.100M $240.1K
YoY Change -8.98% 175.0% -23.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $853.0K $1.600M $460.4K
YoY Change -5.41% 220.0% -55.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.700M $1.700M $1.700M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $1.700M $1.700M $1.700M
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $853.0K $1.600M $460.4K
Total Long-Term Liabilities $1.700M $1.700M $1.700M
Total Liabilities $4.522M $5.300M $4.120M
YoY Change -1.0% 29.27% -12.11%
SHAREHOLDERS EQUITY
Retained Earnings -$312.8M -$301.4M
YoY Change 2.98% 1.37%
Common Stock $24.64K $22.50K
YoY Change 2.28% 29.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $20.95M $22.00M $25.43M
YoY Change
Total Liabilities & Shareholders Equity $25.47M $27.30M $29.55M
YoY Change -18.42% -7.46% 50.99%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$2.215K -$9.195M $3.413M
YoY Change -5.82% 128.25% -240.22%
Depreciation, Depletion And Amortization $9.180K $40.19K $10.00K
YoY Change -10.68% -60.01% -66.67%
Cash From Operating Activities -$3.230M $820.0K -$4.030M
YoY Change -167.71% -107.7% 84.86%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $3.523K -$40.00K
YoY Change -100.0% -91.52%
Acquisitions
YoY Change
Other Investing Activities $0.00 $20.00K
YoY Change
Cash From Investing Activities $0.00 $0.00 -$20.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $580.7K $3.797M
YoY Change -80.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 640.0K 4.160M 70.00K
YoY Change -80.72% -68.89% -84.78%
NET CHANGE
Cash From Operating Activities -3.230M 820.0K -4.030M
Cash From Investing Activities 0.000 0.000 -20.00K
Cash From Financing Activities 640.0K 4.160M 70.00K
Net Change In Cash -2.590M 4.980M -3.980M
YoY Change -132.01% 85.3% 131.4%
FREE CASH FLOW
Cash From Operating Activities -$3.230M $820.0K -$4.030M
Capital Expenditures $0.00 $3.523K -$40.00K
Free Cash Flow -$3.230M $816.5K -$3.990M
YoY Change -167.76% -107.64% 83.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
130000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.88
CY2012Q3 mnov Class Of Warrant Or Right Fair Value
ClassOfWarrantOrRightFairValue
100000
CY2011Q1 mnov Underwritten Public Offering Price Value
UnderwrittenPublicOfferingPriceValue
8250000
CY2012Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30 pure
CY2012Q1 mnov Equity Method Investment Third Party Percentage
EquityMethodInvestmentThirdPartyPercentage
0.70 pure
CY2014Q2 dei Entity Public Float
EntityPublicFloat
43261000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
2500000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24436317 shares
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11882314 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
220000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3008317 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3447969 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2014Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.26
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
869047 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24436317 shares
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694163
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
202147
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1593994
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100977
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
463486
CY2014Q4 us-gaap Assets Current
AssetsCurrent
12132921
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.053 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.30
CY2014Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2013Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
680982
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82414
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
786494
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
461948
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
127643
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
332666935
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
512303
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
461970
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
66761
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1029
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
99850000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
22010589
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310582006
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
345530
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
168403
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
86
CY2014Q4 us-gaap Liabilities
Liabilities
5262905
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
140638
CY2014Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
16536
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
24437
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27273494
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
87370000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
99850000
CY2014Q4 us-gaap Goodwill
Goodwill
9600241
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2145000
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
10699
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14787
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
97894000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
506792
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1448000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
684789
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44844
CY2014Q4 us-gaap Assets
Assets
27273494
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11669435
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
253350
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7557000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
721221
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
800281
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
238655
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1000000
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22495443 shares
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1694163
CY2013Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
9889
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22495443 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
220000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.06
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3217043 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
220000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
22495
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29546243
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1956000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
84537000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
96778000
CY2013Q4 us-gaap Goodwill
Goodwill
9600241
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
151126
CY2014Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
1330000
CY2014Q4 mnov Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
15000 shares
CY2014Q4 mnov Deferred Rent Non Current
DeferredRentNonCurrent
18748
CY2014Q4 mnov Working Capital Net
WorkingCapitalNet
10500000
CY2014Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
14879992
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4010530
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1956000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
460435
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80803
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
186393
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
431193
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
102094
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
326868578
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33894
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
38208
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
96778000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
25425756
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301386714
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1956000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
2200
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240148
CY2013Q4 us-gaap Liabilities
Liabilities
4120487
CY2013Q4 us-gaap Assets
Assets
29546243
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6700493
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
257945
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1763000
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
16854
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
94822000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
513607
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1454000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y29D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
49074 shares
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1956000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7448000
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
238808
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1673560
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
6008553
CY2013Q4 us-gaap Assets Current
AssetsCurrent
14382606
CY2013Q4 mnov Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
99846
CY2013Q4 mnov Deferred Tax Assets Capitalized Expenses
DeferredTaxAssetsCapitalizedExpenses
1576000
CY2013Q4 mnov Deferred Rent Non Current
DeferredRentNonCurrent
9889
CY2013Q4 mnov In Process Research And Development
InProcessResearchAndDevelopment
4800000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24616317 shares
CY2011Q4 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
2500000
CY2011Q1 mnov Common Stock Issued Under Underwritten Public Offering Price Per Share
CommonStockIssuedUnderUnderwrittenPublicOfferingPricePerShare
3.00
CY2011Q1 mnov Common Shares In Underwritten Public Offering
CommonSharesInUnderwrittenPublicOffering
2750000 shares
CY2012Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
680000
CY2012Q3 mnov Class Of Warrant Or Rights Exercisable Period From Date Of Issuance
ClassOfWarrantOrRightsExercisablePeriodFromDateOfIssuance
P15M
CY2012Q3 mnov Other Asset Amortization Period
OtherAssetAmortizationPeriod
P1Y
CY2012Q3 mnov Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2014 dei Trading Symbol
TradingSymbol
MNOV
CY2014 dei Entity Registrant Name
EntityRegistrantName
MEDICINOVA INC
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001226616
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P4Y9M
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.90
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
816529
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.012 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.334 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24067781 shares
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1186352
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9215466
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9223011
CY2014 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6008553
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.58
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Concentrations and Credit Risk</i></b></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Company maintains cash balances at various financial institutions and such balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company also maintains money market funds at various financial institutions which are not federally insured although are invested primarily in U.S. government securities. The Company has not experienced any losses in such accounts and management believes that the Company does not have significant credit risk with respect to such cash and cash equivalents.</p> </div>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Use of Estimates</i></b></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201C;GAAP&#x201D;). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
33374 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.57
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
300000 shares
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.026 pure
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9306536 shares
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
60456
CY2014 us-gaap Other Noncash Income Tax Expense
OtherNoncashIncomeTaxExpense
-9557
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4162261
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M28D
CY2014 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3807
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3523
CY2014 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9227509
CY2014 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
36893
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51350
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
5562
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9199264
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9195292
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
28245
CY2014 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
3685555
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9199264
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20174
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1638038
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-9195292
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2014 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
12518
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
600101
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5963317
CY2014 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
231143
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1638038
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4968942
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-2082
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3523
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-7517
CY2014 us-gaap Operating Expenses
OperatingExpenses
9223011
CY2014 us-gaap License Costs
LicenseCosts
400000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3972
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6325
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
364900
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
63935
CY2014 us-gaap Interest Expense
InterestExpense
628
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51350
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40186
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3972
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5627
CY2014 us-gaap Depreciation
Depreciation
40186
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2900000
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3797361
CY2014 mnov Percentage Of Employee Compensation For Purchase Of Common Stock Under Espp
PercentageOfEmployeeCompensationForPurchaseOfCommonStockUnderEspp
Cannot exceed 15%
CY2014 mnov Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2017-11
CY2014 mnov Capital Loss Carryforward Expiration Year
CapitalLossCarryforwardExpirationYear
2015
CY2014 mnov Cumulative Stock Ownership Change Period
CumulativeStockOwnershipChangePeriod
P3Y
CY2014 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
551955
CY2014 mnov Employee Stock Purchase Plan Offering Period
EmployeeStockPurchasePlanOfferingPeriod
P6M
CY2014 mnov Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
8485
CY2014 mnov Warrant Exercises
WarrantExercises
364900
CY2014 mnov Common Stock Fair Market Value Percentage
CommonStockFairMarketValuePercentage
0.85 pure
CY2014 mnov Employee Stock Purchase Plan Number Of Shares Available For Issuance
EmployeeStockPurchasePlanNumberOfSharesAvailableForIssuance
215953 shares
CY2014 mnov Increase In Ownership Percentage
IncreaseInOwnershipPercentage
0.50 pure
CY2014 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.001 pure
CY2014 mnov Stock Issuance Limit Under Employee Stock Purchase Plan Description
StockIssuanceLimitUnderEmployeeStockPurchasePlanDescription
Shares reserved automatically increase each year by a number equal to the lesser of (i) 15,000 shares; (ii) 1% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year; or (iii) such lesser amount as determined by the Board.
CY2014 mnov Proceeds From Issuance Of Private Placement Net
ProceedsFromIssuanceOfPrivatePlacementNet
3400000
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
87710
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1608000 shares
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41554
CY2013 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
3000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4048522
CY2014 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
3259694
CY2013 us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-3257
CY2013 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13778
CY2014 mnov Effective Income Tax Rate Reconciliation Expiration Of Attributes
EffectiveIncomeTaxRateReconciliationExpirationOfAttributes
-0.054 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10646456
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.022 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.075 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.637 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20697440 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.37
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.036 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.200 pure
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9178110 shares
CY2013 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
20565
CY2013 us-gaap Licenses Revenue
LicensesRevenue
6000000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193951
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
6354
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4024493
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4028528
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
24029
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3257
CY2013 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
12687125
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4024493
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12846
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1216444
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1353334
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4041374
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-4020540
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4307
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6008553
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-4028528
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56487
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13370694
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2013 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
24518
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-41730
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6657989
CY2013 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
259690
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1216444
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2689963
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36754
CY2013 us-gaap Operating Expenses
OperatingExpenses
10023797
CY2013 us-gaap License Costs
LicenseCosts
700000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4035
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2479
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2786000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
2421000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2352000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-2352000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2364000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-2419000
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4800
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100487
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4035
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4035
CY2013 us-gaap Depreciation
Depreciation
36655
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2700000
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13363997
CY2013 mnov Proceeds Or Payments For Issuance Or Repurchase Of Common Stock Net
ProceedsOrPaymentsForIssuanceOrRepurchaseOfCommonStockNet
6697
CY2013 mnov Increase Decrease In Accounts Payable Accrued Expenses Income Taxes Payable And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent
-509900
CY2013 mnov Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
63704
CY2013 mnov Warrant Exercises
WarrantExercises
433131
CY2013 mnov Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.003 pure
CY2013 mnov Research Development And Patents Expense
ResearchDevelopmentAndPatentsExpense
3365808
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2419000
CY2013Q1 us-gaap Revenues
Revenues
3000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2786000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
2788000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2122000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2122000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2131000
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2237000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2237000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2242000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2340000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2340000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2345000
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2381000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-2381000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
2383000
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3413000
CY2013Q4 us-gaap Revenues
Revenues
6000000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
3413000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
2573000

Files In Submission

Name View Source Status
0001193125-15-089483-index-headers.html Edgar Link pending
0001193125-15-089483-index.html Edgar Link pending
0001193125-15-089483.txt Edgar Link pending
0001193125-15-089483-xbrl.zip Edgar Link pending
d843164d10k.htm Edgar Link pending
d843164dex231.htm Edgar Link pending
d843164dex311.htm Edgar Link pending
d843164dex312.htm Edgar Link pending
d843164dex321.htm Edgar Link pending
d843164dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mnov-20141231.xml Edgar Link completed
mnov-20141231.xsd Edgar Link pending
mnov-20141231_cal.xml Edgar Link unprocessable
mnov-20141231_def.xml Edgar Link unprocessable
mnov-20141231_lab.xml Edgar Link unprocessable
mnov-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending